Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study
Vito Lampasona, Massimiliano Secchi, Marina Scavini, et al.
Diabetologia (2020) Vol. 63, Iss. 12, pp. 2548-2558
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Proportion of newly diagnosed diabetes in COVID‐19 patients: A systematic review and meta‐analysis
Thirunavukkarasu Sathish, Nitin Kapoor, Yingting Cao, et al.
Diabetes Obesity and Metabolism (2020) Vol. 23, Iss. 3, pp. 870-874
Open Access | Times Cited: 240
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Daniel J. Drucker
Cell Metabolism (2021) Vol. 33, Iss. 3, pp. 479-498
Open Access | Times Cited: 239
Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis
Giovanni Corona, Alessandro Pizzocaro, Walter Vena, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 2, pp. 275-296
Open Access | Times Cited: 210
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
Yahya Mahamat‐Saleh, Thibault Fiolet, Mathieu E. Rebeaud, et al.
BMJ Open (2021) Vol. 11, Iss. 10, pp. e052777-e052777
Open Access | Times Cited: 164
COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges
Rimesh Pal, Sanjay Kumar Bhadada, Anoop Misra
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 2, pp. 505-508
Open Access | Times Cited: 124
COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality
Prateek Sharma, Tapan Behl, Neelam Sharma, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113089-113089
Open Access | Times Cited: 71
Does poor glycaemic control affect the immunogenicity of the COVID‐19 vaccination in patients with type 2 diabetes: The CAVEAT study
Raffaele Marfella, Nunzia D’Onofrio, Celestino Sardu, et al.
Diabetes Obesity and Metabolism (2021) Vol. 24, Iss. 1, pp. 160-165
Open Access | Times Cited: 94
Diabetes and COVID-19: The past, the present, and the future
Raymond Pranata, Joshua Henrina, Wilson Matthew Raffaello, et al.
Metabolism (2021) Vol. 121, pp. 154814-154814
Open Access | Times Cited: 86
Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination
Hamad Ali, Abdulmohsen Alterki, Sardar Sindhu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 81
Socio-demographic and health factors drive the epidemic progression and should guide vaccination strategies for best COVID-19 containment
Rene Markovič, Marko Šterk, Marko Marhl, et al.
Results in Physics (2021) Vol. 26, pp. 104433-104433
Open Access | Times Cited: 75
High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis
L Gilbert, Jessica Audrey, Vincent Kharisma Wangsaputra, et al.
Diabetes Research and Clinical Practice (2020) Vol. 171, pp. 108561-108561
Open Access | Times Cited: 69
Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention
Tomasz Gęca, Kamila Wojtowicz, Paweł Guzik, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 11, pp. 6555-6555
Open Access | Times Cited: 61
Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection
Arsenio Vargas‐Vázquez, Omar Yaxmehen Bello‐Chavolla, Edgar Ortíz‐Brizuela, et al.
BMJ Open Diabetes Research & Care (2021) Vol. 9, Iss. 1, pp. e002026-e002026
Open Access | Times Cited: 58
Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review
Amir Bahador Boroumand, Mahtab Forouhi, Farzaneh Karimi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
COVID-19 and the Endocrine System: A Review of the Current Information and Misinformation
Samir Mirza, Abdul Ahad Ehsan Sheikh, Michaela Barbera, et al.
Infectious Disease Reports (2022) Vol. 14, Iss. 2, pp. 184-197
Open Access | Times Cited: 44
Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis
Jiajun Li, Yapeng Li, Zhenzhen Wang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 25
Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia
Stefania Dispinseri, Vito Lampasona, Massimiliano Secchi, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 5, pp. 1472-1481
Open Access | Times Cited: 45
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future
Thomas Danne, Catarina Limbert, Manel Puig‐Domingo, et al.
Diabetes Therapy (2021) Vol. 12, Iss. 9, pp. 2289-2310
Open Access | Times Cited: 40
The effectiveness of inactivated SARS‐CoV‐2 vaccine (CoronaVac) on antibody response in participants aged 65 years and older
Murat Karameşe, Emin Ediz Tütüncü
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 173-177
Open Access | Times Cited: 40
Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort
Bénédicte Gaborit, Sara Fernandes, Paul Loubet, et al.
Metabolism (2023) Vol. 142, pp. 155412-155412
Open Access | Times Cited: 20
Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study)
G Molnár, Zoltán Vokó, Gábor Sütő, et al.
BMJ Open Diabetes Research & Care (2024) Vol. 12, Iss. 1, pp. e003777-e003777
Open Access | Times Cited: 6
COVID-19 vaccines: A comprehensive review of safety and efficacy
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 685-777
Closed Access
Neutralising and Non-neutralising Antibodies to SARS-CoV-2: Role during Infection and in the Evolution of Antigenic structure
S. K. Pylaeva, A. A. Sinyugina, Liubov I. Kozlovskaya, et al.
Epidemiology and Vaccinal Prevention (2025) Vol. 23, Iss. 6, pp. 169-176
Open Access
Risk of neonatal SARS-CoV-2 infection: a retrospective cohort study based on infected mothers with gestational diabetes mellitus
Jing Ni, Yong‐Fei Zheng, Jiaqi Tian, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
COVID-19 Vaccinations: A Comprehensive Review of Their Safety and Efficacy in Special Populations
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Vaccines (2021) Vol. 9, Iss. 10, pp. 1097-1097
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top